Daily non-political popular news in brief.

Scientists confirm new virus responsible for deaths of transplant recipients in Australia

02-06-2008 · EurekAlert!

In the first application of high throughput DNA sequencing technology to investigate an infectious disease outbreak, scientists from Columbia University Mailman School of Public Health, the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia, the Centers for Disease Control and 454 Life Sciences link the discovery of a new arenavirus to the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia in April 2007.

Keywords: scientists, confirm, virus, responsible, deaths, transplant, recipients, australia, scientist, viru, death, recipient

« Previous | Next »

Similar news on "Scientists confirm new virus responsible for deaths of transplant recipients in Australia":

Scientists discover new virus caused deaths of transplant recipients from single donor
04-23-2007 · EurekAlert!
Scientists in the Greene Infectious Disease Laboratory of the Columbia University Mailman School of Public Health and colleagues in the Victorian Infectious Diseases Reference Laboratory in Melbourne, Australia and 454 Life Sciences have discovered a new virus that was responsible for the deaths of three transplant recipients who received organs from a single donor in Victoria, Australia.
Similar news · Read more »
New virus discovered
04-23-2007 · EurekAlert!
The unfortunate deaths of three organ transplant recipients in Australia this past January has led to the discovery of a new virus. All three had received organs from the same deceased donor in December, and their closely spaced deaths suggested their transplants might have exposed them to a deadly infectious agent.
Similar news · Read more »
Setting the Stage to Find Drugs Against SARS
11-14-2006 · Brookhaven National Laboratory
Scientists at Brookhaven have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002. Researchers from Brookhaven's biology department and the National Synchrotron Light Source characterized a component of the virus that will be the target of new anti-SARS virus drugs.
Similar news · Read more »
Setting the Stage to Find Drugs Against SARS
11-17-2006 · Brookhaven National Laboratory
Scientists at Brookhaven have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002. Researchers from Brookhaven's biology department and the National Synchrotron Light Source characterized a component of the virus that will be the target of new anti-SARS virus drugs.
Similar news · Read more »
Hib vaccine: A critical ally in Asia's effort to reduce child deaths
06-28-2007 · EurekAlert!
A new study shows Hib vaccine protects children from significant burden of life-threatening pneumonia and meningitis.The study shows Hib vaccine could prevent about one-third of life-threatening cases of bacterial pneumonia, the leading infectious cause of death in Asian children. Findings confirm burden of Hib pneumonia and meningitis grossly underestimated in Asia. More Asian countries are now planning introduction of Hib vaccine, while others still considering this option.
Similar news · Read more »
Protein enhances lethality of influenza virus
10-10-2007 · EurekAlert!
The 1918 influenza virus pandemic was responsible for more than 40 million deaths across the globe. The incredible lethality of the 1918 flu strain is not well understood, despite having been under intense scrutiny for many years. Now, a new study published by Cell Press in the October issue of the journal Cell Host & Microbe unravels some of the mystery surrounding the devastating 1918 pandemic and provides key information that will help prepare for future pandemics.
Similar news · Read more »
Scientists identify cells responsible for relapse after treatment in common childhood cancer
03-29-2007 · EurekAlert!
Researchers led by Professor Murray Norris in the Molecular Diagnostics Program at the Children’s Cancer Institute Australia used a highly sensitive technique to characterize the small population of unique leukaemia cells responsible for relapse in patients diagnosed with acute lymphoblastic leukaemia (ALL), the most common cancer in children.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Possible Hepatitis C vaccine
09-03-2007 · EurekAlert!
Hepatitis C virus infects up to 500,000 people in the UK alone, many of the infections going undiagnosed. It is the single biggest cause of people requiring a liver transplant in Britain. Now scientists have found monoclonal antibodies which may make a successful vaccine a reality, researchers heard today, Sept. 4, 2007, at the Society for General Microbiology's 161st Meeting at the University of Edinburgh, UK, which runs Sept. 3-6, 2007.
Similar news · Read more »
Gene that governs toxin production in deadly mold found
04-12-2007 · EurekAlert!
For the growing number of people with diminished immune systems -- cancer patients, transplant recipients, those with HIV/AIDS -- infection by a ubiquitous mold known as Aspergillus fumigatus can be a death sentence.
Similar news · Read more »